Lung Cancer App (LuCApp) study protocol: a randomised controlled trial to evaluate a mobile supportive care app for patients with metastatic lung cancer.

BMJ Open · 2019 · PMC6398637 · PMID 30772862

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

Although recent advances in cancer therapies have led to better clinical outcomes, 3 treatment-related side effects may be significant and consequently may have an impact on treatment adherence, frequency of hospitalisations and related costs as well as patients’ and their carers’ health-related quality of life (HRQoL).

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.